Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 4c ; Offers Guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.81, $0.04 better than the analyst estimate of $1.77. Revenue for the quarter came in at $1.91 billion versus the consensus estimate of $1.89 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2025 EPS of $7.90-$8.10, versus the consensus of $8.21.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• RBC Capital on Veeva Systems (VEEV) Amid After Hours Selloff on Earnings: 'we are surprised to see shares trade down'
• Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c